CDC: Precancerous cervical lesions on decline in young women
Precancerous cervical lesions associated with human papillomavirus declined sharply in women aged 18–24 between 2008 and 2016, likely reflecting increasing HPV vaccination and changes in detection of these lesions due to updated cervical cancer screening and management recommendations, the Centers for Disease Control and Prevention reported today. Screen-detected, high-grade cervical lesions develop within a few years after infection and have been used to monitor HPV vaccine impact because HPV-associated cancers typically take decades to develop. In 2006, HPV vaccine was licensed and recommended for girls aged 11-12 and for catch-up vaccination through age 26.
Related News Articles
Headline
The Census Bureau reported (https://www2.census.gov/library/publications/2025/demo/acsbr-024.pdf) that the uninsured rate increased nationally to 8.2% in 2024…
Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Perspective
Congress returns to Washington, D.C., this week facing a long list of things to do, including several that will impact hospitals’ ability to provide access to…
Headline
The Department of Health and Human Services Sept. 4 announced new hardship exemption guidance that would allow consumers ineligible for premium tax credits or…
Headline
The Centers for Medicare & Medicaid Services Innovation Center Sept. 2 announced changes to the Achieving Healthcare Efficiency through Accountable Design…